Sun Pharma: Kirti Ganorkar to succeed Dilip Shanghvi as new MD
Mumbai: Sun Pharmaceutical Industries Limited has announced the appointment of Kirti Ganorkar as the company's next Managing Director, effective September 1, 2025, succeeding the company's current Managing Director, Dilip Shanghvi. In the new role, Ganorkar will take over the responsibility for the company’s entire business and functions reporting to him.
This appointment is subject to approval of the shareholders at the upcoming Annual General Meeting.
As Executive Chairman, Shanghvi will continue to chair the Board. He will focus on strengthening Sun Pharma’s specialty portfolio and provide insights towards shaping company’s long-term strategy, as per Sun Pharma's release.
Kirti Ganorkar has been heading India Business at Sun Pharma since June 2019. Under his leadership, the company’s India Business has grown consistently, further increasing its market share.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.